Accuracy of Plasma B-Type Natriuretic Peptide to Diagnose Significant Cardiovascular Disease in Children. The Better Not Pout Children! Study

Journal of the American College of Cardiology

Volumn 54, Issue 15, 2009, Pages 1467-1475

  Law, Yuk M ^a   Hoyer, Andrew W ^b   Reller, Mark D ^c   Silberbach, Michael ^c  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

B type natriuretic peptide; biomarkers; cardiovascular disease; children; heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; AGE FACTORS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; HEART FAILURE; HUMANS; INFANT; INFANT, NEWBORN; LENGTH OF STAY; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 70349462667     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.020     Document Type: Article

References (27)

1. Birkebok N.H., Hansen L.K., Elle B., et al. Chest roentgenogram in the evaluation of heart defects in asymptomatic infants and children with a cardiac murmur: reproducibility and accuracy. Pediatrics 103 (1999) E15
2. Satou G.M., Lacro R.V., Chung T., Gauvreau K., and Jenkins K.J. Heart size on chest x-ray as a predictor of cardiac enlargement by echocardiography in children. Pediatr Cardiol 22 (2001) 218-222
3. Pucci A., Wharton J., Arbustini E., et al. Localization of brain and atrial natriuretic peptide in human and porcine heart. Int J Cardiol 34 (1992) 237-247
4. Ikeda T., Matsuda K., Itoh H., et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. Am Heart J 133 (1997) 307-314
5. Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
6. McCullough P.A., Nowak R.M., McCord J., et al., BNP Multinational Study Investigators. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002) 416-422
7. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
8. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209
9. Dao Q., Krishnaswamy P., Kazanegra R., et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37 (2001) 379-385
10. Tang W.H. B-type natriuretic peptide: a critical review. Congest Heart Fail 13 (2007) 48-52
11. Mir T.S., Flato M., Falkenberg J., et al. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender. Pediatr Cardiol 27 (2006) 73-77
12. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
13. Mir T.S., Laux R., Hellwege H.H., et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112 (2003) 896-899
14. Mir T.S., Marohn S., Laer S., Eiselt M., Grollmus O., and Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110 (2002) e76
15. Mir T.S., Falkenberg J., Friedrich B., et al. Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol Young 15 (2005) 396-401
16. Law Y.M., Keller B.B., Feingold B.M., and Boyle G.J. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 95 (2005) 474-478
17. Law Y.M., Ettedgui J., Beerman L., Maisel A., and Tofovic S. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 98 (2006) 520-524
18. Koulouri S., Acherman R.J., Wong P.C., Chan L.S., and Lewis A.B. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 25 (2004) 341-346
19. Cohen S., Springer C., Avital A., et al. Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?. Pediatrics 115 (2005) 1347-1350
20. Maher K.O., Reed H., Cuadrado A., et al. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Pediatrics 121 (2008) e1484-e1488
21. Rudolph A.M. The changes in the circulation after birth. Their importance in congenital heart disease. Circulation 41 (1970) 343-359
22. Friedman W.F. The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis 15 (1972) 87-111
23. Silberbach M., Stejskal E., Foker J., et al. Newborn cardiorenal dynamics: a state of atrial natriuretic peptide unresponsiveness. Am J Physiol 261 (1991) H2069-H2074
24. Zhao L., Mason N.A., Strange J.W., Walker H., and Wilkins M.R. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity. Circulation 107 (2003) 234-237
25. Baliga R.S., Zhao L., Madhani M., et al. Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension. Am J Respir Crit Care Med 178 (2008) 861-869
26. Jin H., Yang R.H., Chen Y.F., Jackson R.M., and Oparil S. Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia. J Clin Invest 85 (1990) 115-120
27. Price J.F., Thomas A.K., Grenier M., et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 114 (2006) 1063-1069